898291-26-4

Upstream product

• 100-83-4 meta-hydroxybenzaldehyde 
• 17356-08-0 thiourea 
• 365404-54-2 3-oxo-5-triisopropylsilanyloxy-pentanoic acid ethyl ester 

Downstream Products

• 898291-32-2 6-(2-Hydroxy-ethyl)-4-(3-hydroxy-phenyl)-2-thioxo-1,2,3,4-tetrahydro-pyrimidine-5-carboxylic acid ethyl ester 
• 898291-34-4 4-(3-hydroxyphenyl)-2-thioxo-3,4,7,8-tetrahydro-1H-pyrano[4,3-d]pyrimidin-5(2H)-one 

Relevant academic research and scientific papers

Bicyclic Dihydropyrimidines and Uses Thereof

The present invention provides compounds having formula (I): (I) and pharmaceutically acceptable derivatives thereof; as described generally and in subclasses herein, which compounds are useful as kinesin inhibitors (e.g., Eg5 inhibitors), and thus are useful, for example, for the treatment of proliferative disorders e.g., cancer. The invention additionally provides methods for preparing compounds of the invention, compositions comprising them, and methods for the use thereof in the treatment of various disorders where Eg5 is involved. In certain embodiments, the present invention provides for compounds, compositions, methods and systems for inhibiting cell growth. More specifically, the present invention provides for methods, compounds and compositions which are capable of inhibiting mitosis in metabolically active cells. Compounds, compositions and methods of the present invention inhibit the activity of a protein involved in the assembly and maintenance of the mitotic spindle. One class of proteins which acts on the mitotic spindle is the family of mitotic kinesins, a subset of the kinesin superfamily.